Yale Researchers Uncover Key Proteins Driving Parkinson’s Disease Spread, Offering Hope for New Therapies
New Haven, CT – Groundbreaking research from Yale School of Medicine (YSM) has identified two critical proteins on the surface of motor neurons that appear to facilitate the spread of…
Rethinking Cerebellar Research: Virginia Tech Study Challenges Long-Held Assumptions in Neurological Disease Study
New research from a Virginia Tech neuroscientist at the Fralin Biomedical Research Institute at VTC is raising questions about a long-standing approach to studying chronic neurological conditions such as dystonia,…
Chlorpyrifos Exposure Significantly Increases Parkinson’s Disease Risk, UCLA Study Reveals
A groundbreaking study from UCLA Health has established a potent link between long-term residential exposure to the widely used agricultural pesticide chlorpyrifos and a significantly elevated risk of developing Parkinson’s…
The Astonishing Power of Two Micrograms: Vitamin B12’s Century-Long Journey from Fatal Disease to Cellular Energy
Two micrograms. This infinitesimal amount, weighing less than a mere speck of table salt, represents the daily requirement of vitamin B12 for adults, a nutrient crucial for red blood cell…
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer’s disease phenotypes
New scientific research published in the journal Alzheimer’s & Dementia has identified a critical intersection between genetic predisposition and lifestyle factors in the development of Alzheimer’s disease. The study, led…
A Promising New Avenue for Alzheimer’s Treatment: Experimental Molecule Reprograms Brain’s Immune Cells to Combat Disease
Researchers in Spain and Switzerland have identified an experimental molecule that may help restore the brain’s natural defenses against Alzheimer’s disease. The compound, known as OLE, appears to "reprogram" microglia,…
A Novel Theory Emerges: Alzheimer’s Disease May Originate from Protein Interference Within Nerve Cells
Researchers at the University of California, Riverside (UCR) have put forth a groundbreaking hypothesis that could fundamentally alter our understanding of Alzheimer’s disease. Challenging decades of established dogma, their new…
A Promising Experimental Compound Targets a Novel Pathway in Alzheimer’s Disease Progression
A groundbreaking experimental compound, developed through nearly two decades of dedicated research at ETH Zurich, is showing significant promise in offering a novel therapeutic avenue for slowing the relentless progression…
Monash University Researchers Uncover Promising Copper-Based Therapeutic Avenue for Alzheimer’s Disease
Researchers at Monash University have identified a groundbreaking therapeutic strategy that could significantly alter the landscape of Alzheimer’s disease treatment. In rigorous laboratory studies, a novel copper-based compound demonstrated a…
Unlocking Alzheimer’s: Cancer-Driving Mutations in Brain Immune Cells Reveal Novel Disease Pathway
The aging process is intrinsically linked to cellular changes, with our cells accumulating genetic mutations over time. A groundbreaking study from Boston Children’s Hospital, published in the esteemed journal Cell,…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple














